Q9BYF1 (ACE2_HUMAN) Homo sapiens (Human)

Angiotensin-converting enzyme 2 UniProtKBInterProSTRINGInteractive Modelling

805 aa; Sequence (Fasta) ; (Isoform 3)

Available Structures

116 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
ACE2-B0AT1 complex Heteromer
Q695T7; 		14×NAG; 10×NAG; 4×3PH; 2×ZN;
6m18
20-768
Assess
ACE2-B0AT1 complex, open conformation Heteromer
Q695T7;
6m1d
21-768
Assess
The 2019-nCoV RBD/ACE2-B0AT1 complex Heteromer
P0DTC2; Q695T7; 		14×NAG; 2×NAG; 10×NAG; 2×LEU; 2×ZN;
6m17
21-768
Assess
Conformation 1 of S-ACE2-B0AT1 ternary complex Heteromer
P0DTC2; Q695T7; 		58×NAG; 64×NAG; 2×LEU; 2×ZN;
7dwx
21-768
Assess
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1 Heteromer
P0DTC2;
7l7f
21-731
Assess
Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) Heteromer
3×NAG; 1×CL; 1×ZN;
1r42
19-615
Assess
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 Heteromer
P0DTC2; 		1×ZN; 1×CL; 5×NAG;
6m0j
19-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus huma… Heteromer
P59594; Q56NL1; 		5×NDG; 2×ZN; 2×CL; 1×NAG;
3d0g
19-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus cive… Heteromer
P59594; Q56NL1; 		5×NDG; 2×ZN; 2×CL; 1×NAG;
3d0i
19-615
Assess
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor Heteromer
P59594; 		1×NAG; 4×NAG; 1×ZN; 1×CL;
2ajf
19-615
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human … Heteromer
P59594; 		1×ZN; 1×CL;
3sci
19-615
Assess
Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) Heteromer
2×NAG; 1×CL; 1×ZN; 1×XX5;
1r4l
19-615
Assess
Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain co… Heteromer
P59594; Q56NL1; 		1×ZN; 1×CL;
3scl
19-615
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594; 		1×ZN; 1×CL;
3scj
19-615
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594; Q56NL1; 		1×ZN; 1×CL;
3sck
19-615
Assess
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunoc… Heteromer
A0A7U0MIF7; 		1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×NAG;
7sn0
19-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus cive… Heteromer
P59594; Q56NL1; 		5×NDG; 2×ZN; 2×CL; 1×NAG;
3d0h
19-615
Assess
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 Heteromer
P0DTC2; 		2×NAG; 2×NAG; 1×NAG; 1×NAG; 1×ZN; 1×SO4;
7dmu
19-615
Assess
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 … Heteromer
P0DTC2; 		6×NAG; 1×ZN;
7rpv
19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
6acg
19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
6acj
19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
6ack
19-615
Assess
SARS-CoV-2 S-ACE2 complex Heteromer
P0DTC2; 		18×NAG; 36×NAG;
7df4
19-615
Assess
The structure of FC08 Fab-hA.CE2-RBD complex Heteromer
P0DTC2; 		5×NAG;
7dx4
19-615
Assess
SARS-COV-2 Spike RBDMACSp25 binding to hACE2 Heteromer
P0DTC2; 		5×NAG;
7fdh
19-615
Assess
SARS-COV-2 Spike RBDMACSp6 binding to hACE2 Heteromer
P0DTC2; 		5×NAG;
7fdg
19-615
Assess
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD Heteromer
A0A6G6A2Q2; 		1×ZN; 5×NAG;
7ddp
19-615
Assess
Cryo-EM structure of human ACE2 and GD/1/2019 RBD Heteromer
A0A7D6PMV8; 		1×ZN; 4×NAG;
7ddo
19-615
Assess
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a Heteromer
P0DTC2;
7vxa
19-615
Assess
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1 Heteromer
P0DTC2;
7vx9
19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state Heteromer
P0DTC2;
7vxf
19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state Heteromer
P0DTC2;
7vxd
19-615
Assess
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex Heteromer
P0DTC2; 		1×ZN; 5×NAG;
7vx5
19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state Heteromer
P0DTC2;
7vxk
19-615
Assess
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex Heteromer
P0DTC2; 		1×ZN; 1×CL; 5×NAG;
7dqa
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C2a Heteromer
P0DTC2;
7w99
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C1 Heteromer
P0DTC2;
7w98
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C2b Heteromer
P0DTC2;
7w9b
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C3 Heteromer
P0DTC2;
7w9c
19-615
Assess
SARS-CoV-2 Delta S-RBD-ACE2 Heteromer
P0DTC2;
7w9i
19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state Heteromer
P0DTC2;
7vxm
19-615
Assess
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex Heteromer
P0DTC2; 		1×ZN; 5×NAG;
7vx4
19-615
Assess
SARS-CoV-2 Kappa variant spike protein in C3 state Heteromer
P0DTC2;
7vxc
19-615
Assess
SARS-CoV-2 Kappa variant spike protein in C2b state Heteromer
P0DTC2;
7vxb
19-615
Assess
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 Heteromer
P0DTC2; 		4×NAG; 1×ZN;
7ekh
19-614
Assess
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 Heteromer
P0DTC2; 		1×NAG; 4×NAG; 3×EDO; 1×ZN;
7lo4
19-614
Assess
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T2… Heteromer
P0DTC2; 		5×NAG;
7efr
19-614
Assess
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 Heteromer
P0DTC2; 		4×NAG; 1×ZN;
6lzg
19-614
Assess
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2 Heteromer
P0DTC2; 		1×NAG; 5×NAG; 1×ZN;
7ekg
19-614
Assess
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 Heteromer
P0DTC2; P59594; 		3×NAG; 2×NAG; 1×ZN; 1×CL; 1×EDO; 1×NAG;
6vw1
19-614
Assess
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S1… Heteromer
P0DTC2; 		5×NAG;
7efp
19-614
Assess
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2 Heteromer
P0DTC2; 		4×NAG; 1×ZN;
7eke
19-614
Assess
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immuni… Heteromer
P0DTC2; 		1×NAG; 8×CL; 1×SO4; 4×NA; 1×PG5; 1×ZN; 4×NAG; 1×PGE;
7l0n
19-614
Assess
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2 Heteromer
P0DTC2; 		1×NAG; 5×NAG; 1×ZN;
7ekc
19-614
Assess
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2 Heteromer
P0DTC2; 		1×NAG; 4×NAG; 1×ZN;
7ekf
19-614
Assess
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2 Heteromer
A0A6B9WHD3; 		2×NAG; 4×NAG; 1×ZN;
7drv
19-614
Assess
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in co… Heteromer
P0DTC2; 		5×NAG;
7nxc
19-614
Assess
Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human … Heteromer
Q6Q1S2; 		8×NAG;
3kbh
19-614
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
P0DTC2; 		5×NAG; 46×NAG;
7knb
19-614
Assess
ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2… Heteromer
P0DTC2; 		2×NAG; 5×NAG;
7kmb
19-614
Assess
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
P0DTC2; 		8×NAG; 55×NAG;
7kms
19-614
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 Heteromer
P0DTC2; 		6×NAG; 44×NAG;
7kne
19-614
Assess
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
P0DTC2; 		4×NAG; 48×NAG;
7knh
19-614
Assess
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
P0DTC2; 		6×NAG; 56×NAG;
7kni
19-614
Assess
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 Heteromer
P0DTC2; 		4×NAG; 53×NAG;
7kmz
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2; 		5×NAG;
7mjn
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2; 		18×NAG; 32×NAG;
7mjm
19-614
Assess
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 … Heteromer
P0DTC2; 		1×NAG; 4×NAG; 3×NAG;
7v8b
19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … Heteromer
P0DTC2; 		37×NAG; 13×NAG;
7v86
19-614
Assess
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (AC… Heteromer
P0DTC2; 		3×NAG; 5×NAG;
7v80
19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … Heteromer
P0DTC2; 		31×NAG; 13×NAG;
7v85
19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enz… Heteromer
P0DTC2; 		31×NAG; 17×NAG;
7v7z
19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
P0DTC2; 		30×NAG; 29×NAG;
7v83
19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
P0DTC2; 		43×NAG; 14×NAG;
7v89
19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
P0DTC2; 		38×NAG; 16×NAG;
7v8a
19-614
Assess
Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2)… Heteromer
P0DTC2; 		5×NAG; 3×NAG;
7v84
19-614
Assess
Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 … Heteromer
P0DTC2; 		2×NAG; 1×NAG; 4×NAG;
7v87
19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
P0DTC2; 		30×NAG; 1×NAG; 19×NAG;
7v81
19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
P0DTC2; 		37×NAG; 15×NAG;
7v88
19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
P0DTC2; 		29×NAG; 26×NAG;
7v82
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2; 		18×NAG; 26×NAG;
7sxx
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2; 		7×NAG;
7sy0
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… Heteromer
P0DTC2; 		7×NAG;
7sy8
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… Heteromer
P0DTC2; 		18×NAG; 26×NAG;
7sy3
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… Heteromer
P0DTC2; 		7×NAG;
7sy4
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2; 		7×NAG;
7sxy
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… Heteromer
P0DTC2; 		18×NAG; 28×NAG;
7sy7
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2; 		7×NAG;
7sy2
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2; 		18×NAG; 28×NAG;
7sxz
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… Heteromer
P0DTC2; 		18×NAG; 42×NAG;
7sy5
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2; 		18×NAG; 28×NAG;
7sy1
19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… Heteromer
P0DTC2; 		7×NAG;
7sy6
19-614
Assess
SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain Heteromer
P0DTC2; 		1×ZN; 3×NAG;
7bh9
19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound Heteromer
P0DTC2; 		23×NAG; 1×ZN;
7a94
19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction Heteromer
P0DTC2;
7a95
19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound Heteromer
P0DTC2;
7a98
19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction Heteromer
P0DTC2;
7a96
19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound Heteromer
P0DTC2;
7a97
19-613
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
P0DTC2; 		1×NAG; 7×NAG; 1×ZN;
7a91
19-613
Assess
S protein of SARS-CoV-2 in complex bound with T-ACE2 Heteromer
P0DTC2; 		35×NAG; 34×NAG;
7ct5
21-615
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) Heteromer
P0DTC2; 		1×NAG; 7×NAG; 1×ZN;
7a92
19-613
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and … Heteromer
P0DTC2; 		27×NAG; 28×NAG;
7dx7
21-615
Assess
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound) Heteromer
P0DTC2; 		26×NAG; 30×NAG;
7dx5
21-615
Assess
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound) Heteromer
P0DTC2; 		27×NAG; 28×NAG;
7dx6
21-615
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and … Heteromer
P0DTC2; 		32×NAG; 29×NAG;
7dx9
21-615
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and … Heteromer
P0DTC2; 		32×NAG; 29×NAG;
7dx8
21-615
Assess
SARS-CoV-2 B.1.1.7 S-ACE2 complex Heteromer
P0DTC2; 		16×NAG; 27×NAG;
7fem
19-613
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 Heteromer
P0DTC2; 		18×NAG; 34×NAG;
7t9k
19-613
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinemen… Heteromer
P0DTC2; 		7×NAG;
7t9l
19-613
Assess
SARS-COV-2 Spike RBDMACSp36 binding to hACE2 Heteromer
P0DTC2; 		5×NAG;
7fdi
19-612
Assess
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound Heteromer
P0DTC2; 		20×NAG; 40×NAG;
7kj3
21-613
Assess
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound Heteromer
P0DTC2; 		24×NAG; 42×NAG;
7kj4
21-613
Assess
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound Heteromer
P0DTC2; 		17×NAG; 36×NAG;
7kj2
21-613
Assess
The co-crystal structure of ACE2 with Fab Heteromer
1×ZN;
7e7e
23-613
Assess
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles Heteromer
P59594; 		9×NAG; 7×NAG; 11×NAG; 6×NAG;
6cs2
19-562
Assess
Importin alpha bound to the C-terminus of ACE2 Heteromer
P52293;
7jvo
768-774
Assess

3 SWISS-MODEL models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer1×NAG; 1×ZN;0.846m17.1.B21-768
100.00
Assess
Heteromer
Q9BYF1; P0DTC2; 		4×NAG;0.787mjm.119-614
99.45
Assess
Heteromer
P0DTC2; 		5×NAG; 9×NAG;0.737kj2.121-613
99.67
Assess

2 SWISS-MODEL models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 3monomer1×ZN;0.786m18.1.B7-422
99.12
Assess
Isoform 3monomer0.573abm.1.B380-402
13.04
Assess